Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.05% for Myopia Control After Pediatric Cataract Surgery
NCT07364370Not yet recruiting
- Sponsor
- Cairo University
- Start
- Feb 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial of NVK002 in myopia (2 arms), sponsored by Cairo University. Primary endpoints: Change in spherical equivalent at 12 months and Change in axial length at 12 months. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07364370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07364370.